Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5505790 | Biochemical and Biophysical Research Communications | 2017 | 27 Pages |
Abstract
Our findings suggest that although plasmin has been suggested to be a driver for disease progression using clinical patient samples in MM using mostly in vitro studies, here we demonstrate that suppression of plasmin generation or inhibition of plasmin cannot alter MM progression in vivo.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Salita Eiamboonsert, Yousef Salama, Hiroshi Watarai, Douaa Dhahri, Yuko Tsuda, Yoshio Okada, Koichi Hattori, Beate Heissig,